Diagnostic Accuracy and Clinical Impact of FDG-PET/CT Follow-Up for Patients on Adjuvant Immunotherapy for High-Risk Malignant Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma
Eur. J. Nucl. Med. Mol. Imaging 2022 Jun 01;49(7)2342-2351, JAS Andersen, AD Spatzek, MH Vilstrup, P Grupe, S Hess, PC Holdgaard, L Bastholt, O Gerke, MG HildebrandtFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.